Marc R' Solochek

1

• Marc R. Solochek
• Chief Executive Officer

2
The Problem

• Preeclampsia
• A life-threatening health care issue

3
Preeclampsia Hypertension during Pregnancy

• High blood pressure affects 8-10 of the 4
  million deliveries each year
• A leading cause of prematuritya major factor in
  newborn damage
• The leading cause of maternal death world wide
• Annual cost for care of premature babies in US
  18 billion

4
KEY PEOPLE

• Marc R. Solochek, CEO
• David G. Chaffin, M.D., CMO
• Denise G. Webb, R.N.C., Director of Prenatal
  Services
• Tom Pressman, Interim Director of Marketing

5
Ohms 1.0 at Cabell-Huntington Hospital

• Over 400 deliveries
• Average gestation - 37 weeks
• Average NICU days less than 4
• Infant Mortalities - ZERO

6
UNTAPPED NEW MARKET

• 3,000 Hospital affiliated OB clinics
• 3,000 Independent OB clinics
• 30,000 Licensed obstetricians

7
MIST Competition

• Existing medical inertia
• Typical technology adoption curve
• Informal channels of communication
• Competing ICG machine manufacturers
• No clinical background on which to base claims
• MIST has a two year lead
• Copycat software
• Patent protecting software, process, and data
  uses
• MIST has a two year lead

8
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product

9
Who Benefits?

• Patients
• Newborns
• Families
• Physicians
• Employers
• Third party payers

10
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product
• A major health care problem has been solved

11
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product
• A major health care problem has been solved
• We have a proven product, ready to market

12
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product
• A major health care problem has been solved
• We have a proven product, ready to market
• There is a large market that will want . . .no,
  need our product

13
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product
• A major health care problem has been solved
• We have a proven product, ready to market
• There is a large market that will want . . .no,
  need our product
• Cost savings to the market is enormous

14
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product
• A major health care problem has been solved
• We have a proven product, ready to market
• There is a large market that will want . . .no,
  need our product
• Cost savings to the market is enormous
• We are first to market . . . a 2 year lead

15
Why MIST Will Succeed

• There are numerous constituencies that will
  benefit from our product
• A major health care problem has been solved
• We have a proven product, ready to market
• There is a large market that will want . . .no,
  need our product
• Cost savings to the market is enormous
• We are first to market . . . a 2 year lead
• We have an experienced business team . . . been
  partnering for almost 3 years

16
(No Transcript)